0 results for 'Kramer Levin Naftalis'
Orrick, Kramer Levin Step Into Silicon Valley Bank Securities Litigation
This suit was surfaced by Law.com Radar. Read the complaint here.Back to Reality: The 2023 Am Law 100 Super Rich
Reaching the upper-echelon thresholds of revenue per lawyer and profit per lawyer proved more elusive for firms in The Am Law 100 this year.Why the Am Law 100 Is Hiring More Private Investigators
A Q&A with Dan Nardello, CEO of a global investigations firm Nardello & Co., on the business and ethics of working for law firms on highly contentious matters.Another Hefty Batch of Litigator of the Week Runners-Up and Shout Outs
First runners-up this week at Davis Wright Tremaine who won a high-profile fair use fight for book publishers against the Internet Archive.What Goes Up Must Come Down: NY Firms Come Back to Earth After Record 2021
Double-digit drops in revenue, PEP and other key financial metrics were the norm in 2022 for New York's elite firms.View more book results for the query "Kramer Levin Naftalis "
Kramer Levin Wins in Dispute Over Multibillion-Dollar Texas Development With Georgia Ties
U.S. District Judge Lewis Liman also declined the plaintiffs' request that he transfer the case back to Georgia, where it originated as part of a bankruptcy proceeding in 2020.Kramer Levin Wins Dismissal in Lender Liability Dispute Over Multibillion-Dollar Texas Development
U.S. District Judge Lewis Liman also declined the plaintiffs' request that he transfer the case back to Georgia, where it originated as part of a bankruptcy proceeding in 2020.Current and Former New York Elected Officials Side With Ex-Lt. Gov. Brian Benjamin in Amicus Brief
U.S. District Judge J. Paul Oetken of the Southern District of New York partially granted former Benjamin's motion to dismiss his indictment in December, throwing out bribery and fraud charges while allowing the case to proceed on two falsification of records charges.Why the Supreme Court Should Reject Attempts to Monopolize a Therapeutic Target
Patents that lay claim to all antibody therapeutics for a biological target stifle medical innovation and hurt patients.Another Round of Litigator of the Week Runners-Up and Shout Outs
Litigators at Baker Botts knocked out a nine-digit verdict against DISH Network in a patent showdown with ClearPlay Inc.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Employee Happiness Playbook: The 3 R's for Business Success in 2024
Brought to you by Amazing Workplace, Inc.
Download Now
The Positive Impact of AI at Small Law Firms: 4 Key Insights
Brought to you by LexisNexis®
Download Now
Will Generative AIs Transform Legal Services? Defensibility and Security Must Be a Focus
Brought to you by HaystackID
Download Now
Unlocking the Power of Early Case Assessment Workflows
Brought to you by Integreon
Download Now